Polysaccharide production by lactic acid bacteria: from genes to industrial applications

AA Zeidan, VK Poulsen, T Janzen… - FEMS microbiology …, 2017 - academic.oup.com
The ability to produce polysaccharides with diverse biological functions is widespread in
bacteria. In lactic acid bacteria (LAB), production of polysaccharides has long been …

[HTML][HTML] CRISPR/Cas9 landscape: current state and future perspectives

M Tyumentseva, A Tyumentsev, V Akimkin - International journal of …, 2023 - mdpi.com
CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 is a unique
genome editing tool that can be easily used in a wide range of applications, including …

Perinatal Streptococcus agalactiae epidemiology and surveillance targets

LL Furfaro, BJ Chang, MS Payne - Clinical microbiology reviews, 2018 - journals.asm.org
Streptococcus agalactiae, or group B streptococcus (GBS), is a major neonatal pathogen.
Recent data have elucidated the global prevalence of maternal and neonatal colonization …

[HTML][HTML] Invited review: a critical appraisal of mastitis vaccines for dairy cows

P Rainard, FB Gilbert, P Germon, G Foucras - Journal of dairy science, 2021 - Elsevier
Infections of the mammary gland remain a frequent disease of dairy ruminants that
negatively affect animal welfare, milk quality, farmer serenity, and farming profitability and …

Serotype distribution, population structure, and antimicrobial resistance of group B Streptococcus strains recovered from colonized pregnant women

S Teatero, P Ferrieri, I Martin, W Demczuk… - Journal of clinical …, 2017 - journals.asm.org
Using seroty**, multilocus sequence ty**, and whole-genome sequencing (WGS) of
selected strains, we studied the population structure of 102 group B Streptococcus (GBS) …

Population genomics of Group B Streptococcus reveals the genetics of neonatal disease onset and meningeal invasion

C Chaguza, D Jamrozy, MW Bijlsma… - Nature …, 2022 - nature.com
Abstract Group B Streptococcus (GBS), or Streptococcus agalactiae, is a pathogen that
causes preterm births, stillbirths, and acute invasive neonatal disease burden and mortality …

Increasing incidence of group B streptococcus neonatal infections in the Netherlands is associated with clonal expansion of CC17 and CC23

D Jamrozy, MW Bijlsma, MC de Goffau… - Scientific Reports, 2020 - nature.com
Group B streptococcus (GBS) is the leading cause of neonatal invasive disease worldwide.
In the Netherlands incidence of the disease increased despite implementation of preventive …

Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern …

E Campisi, R Rosini, W Ji, S Guidotti… - Frontiers in …, 2016 - frontiersin.org
Neonatal invasive disease caused by group B Streptococcus (GBS) represents a significant
public health care concern globally. However, data related to disease burden, serotype …

GBS-SBG-GBS seroty** by genome sequencing

S Tiruvayipati, WY Tang, TMS Barkham… - Microbial …, 2021 - microbiologyresearch.org
Group B Streptococcus (GBS; Streptococcus agalactiae) is the most common cause of
neonatal meningitis and a rising cause of sepsis in adults. Recently, it has also been shown …

Real-time PCR-based seroty** of Streptococcus agalactiae

KM Breeding, B Ragipani, KUD Lee, M Malik… - Scientific reports, 2016 - nature.com
Abstract Group B Streptococcus (GBS) is an encapsulated, gram-positive pathogen that is
an important cause of neonatal invasive infections, including sepsis and meningitis. There …